The information in this section about myelodysplastic syndromes (MDS) can help you talk with members of your healthcare team and take an active role in your treatment. Knowing what to expect and being able to make informed decisions about your cancer treatment are important aspects of coping with your disease. You can skim sections to find what you want to read now - and continue reading whenever you're ready for more information.
What You Should Know
- MDS is a diagnosis of cancer.
- Hematologists and oncologists are specialists who treat people who have MDS or other types of blood cancer.
- Treatment outcomes vary widely among patients; results depend on many individual factors.
What You Should Do
- Seek treatment in a cancer center where doctors are experienced treating patients with MDS.
- Talk with your doctor about your diagnostic tests and what the results mean.
- Ask your doctor whether a clinical trial is a good treatment option for you.
What Is MDS?
The term "myelodysplastic syndromes" (MDS) is used to describe a group of diseases of the blood and bone marrow, with varying degrees of severity, treatment needs and life expectancy.
MDS may be primary (de novo) or treatment-related. Primary MDS has no obvious cause. Treatment-related MDS has an obvious cause.
Source: Myelodysplastic Syndromes. Reviewed by Elihu H. Estey, MD.